Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma. - Jurgens E; Shekarkhand T; Rueda C; Nemirovsky D; Derkach A; Firestone RS; Miller K; Costa BA; Rajeeve S; Lesokhin AM; Korde N; Tan CR; et al. (Blood cancer journal, 2025)